Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Geus Aart De sold 5,893 shares of the company’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $602.00, for a total value of $3,547,586.00. Following the transaction, the insider now directly owns 106,983 shares in the company, valued at approximately $64,403,766. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Geus Aart De also recently made the following trade(s):
- On Thursday, June 27th, Geus Aart De sold 8,158 shares of Synopsys stock. The stock was sold at an average price of $602.59, for a total transaction of $4,915,929.22.
- On Tuesday, June 25th, Geus Aart De sold 4,212 shares of Synopsys stock. The shares were sold at an average price of $600.05, for a total transaction of $2,527,410.60.
Synopsys Trading Down 0.4 %
NASDAQ:SNPS opened at $606.99 on Friday. Synopsys, Inc. has a 12-month low of $418.51 and a 12-month high of $629.38. The firm has a market cap of $93.00 billion, a price-to-earnings ratio of 65.98, a price-to-earnings-growth ratio of 3.93 and a beta of 1.07. The company’s 50-day moving average is $574.85 and its two-hundred day moving average is $557.39.
Institutional Investors Weigh In On Synopsys
Several hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Synopsys by 2.1% in the 1st quarter. Vanguard Group Inc. now owns 13,829,357 shares of the semiconductor company’s stock worth $7,903,478,000 after buying an additional 278,265 shares during the last quarter. Capital World Investors grew its holdings in Synopsys by 12.5% in the first quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company’s stock valued at $4,211,892,000 after purchasing an additional 818,485 shares during the period. Price T Rowe Associates Inc. MD increased its position in Synopsys by 39.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company’s stock worth $3,050,441,000 after purchasing an additional 1,514,449 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Synopsys by 6.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,565,534 shares of the semiconductor company’s stock worth $1,321,019,000 after purchasing an additional 153,053 shares during the period. Finally, Norges Bank acquired a new position in shares of Synopsys in the 4th quarter valued at $1,272,143,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on SNPS. Rosenblatt Securities reiterated a “buy” rating and set a $615.00 price target on shares of Synopsys in a research report on Thursday, May 23rd. StockNews.com upgraded Synopsys from a “hold” rating to a “buy” rating in a research report on Monday, March 18th. Piper Sandler restated an “overweight” rating and issued a $672.00 price target (up previously from $665.00) on shares of Synopsys in a research report on Thursday, May 23rd. JPMorgan Chase & Co. boosted their price objective on shares of Synopsys from $650.00 to $655.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Finally, Needham & Company LLC restated a “buy” rating and set a $660.00 target price on shares of Synopsys in a report on Thursday, May 23rd. Eleven analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $625.82.
Get Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Transportation Stocks Investing
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Quiet Period Expirations Explained
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.